We are experienced manufacturer. Wining the majority of the crucial certifications of its market for H Pylori Antigen Rapid Test Cassette, In Vitro Diagnostic Solutions, Helicobacter Antibody Test, We glance forward to giving you with our solutions while in the in the vicinity of future, and you will come across our quotation may be very affordable and the top quality of our merchandise is extremely outstanding!
Well-designed Brucella Antibody Igm - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody Detail:
Product details
Recombinant SARS-CoV-2 Nucleocapsid Protein is produced by Escherichia coli expression system and the target gene Met1-Ala419 is expressed with 6 HIS tag at the N-terminus. Consists of 428 amino acids and predicts a molecular mass of 46.6 kDa.
Properties
Purity |
≥95% (SDS-PAGE) |
Molecular Mass |
46.6 kDa |
Product Buffer |
20mM PB, 150mM NaCl, 10%Glycerol, pH8.0. |
Storage |
Store at -20℃ to -80℃. Avoid multiple freeze/thaw cycles. |
Order Information
Product Name |
Cat. No |
Quantity |
Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) |
AG0046 |
Customized |
Product detail pictures:
Related Product Guide:
Our company puts emphasis on the management, the introduction of talented personnel, and the construction of staff building, trying hard to improve the quality and liability consciousness of staff members. Our company successfully attained IS9001 Certification and European CE Certification of Well-designed Brucella Antibody Igm - Recombinant SARS-CoV-2 Nucleocapsid Protein (N-His) – Bioantibody , The product will supply to all over the world, such as: Denver, Norwegian, Montpellier, Our company offers the full range from pre-sales to after-sales service, from product development to audit the use of maintenance, based on strong technical strength, superior product performance, reasonable prices and perfect service, we'll continue to develop, to deliver the high-quality items and services, and promote lasting cooperation with our customers, common development and create a better future.